Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8766785f6e0553076fce536dce50564d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_035478b2a603c40f7c02e8329f29f47e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_681d1154bf8a7d615747c7ee8bbc0871 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
filingDate |
1997-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fd03f17714bfbfb76004c8962f1aebe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3927f0690390bf2a791886a5e09dd25b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e79250a1e8cfa3768120115b17702f92 |
publicationDate |
1998-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9809649-A1 |
titleOfInvention |
Inhibition of viral replication |
abstract |
The invention relates to methods and compositions for inhibition of viral replication in animal cells. In particular, inhibition of viral replication in a target cell is achieved by introducing into the cell (1) a protein which can be incorporated along with wild type nucleocapsid subunits into a viral nucleocapsid assembling within the cell, and thereby renders the nucleocapsid deficient in encapsidating viral nucleic acid; or (2) a recombinant nucleic acid construct that directs overexpression of the protein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1054689-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1054689-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7323331-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-302092-B6 |
priorityDate |
1996-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |